Skip to main content
Equibles
BEAT logo

BEAT · HeartBeam, Inc. · Webcasts, Transcripts & Audio

Track BEAT — free

Use BEAT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BEAT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.43 +0.02 (+3.72%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on the current business plan assumptions, existing financing arrangements and expected cash burn rate, the Company believes that its existing liquidity is insufficient to fund operations for the next twelve months following the issuance of these financial statements. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$24.61M
Shares
56.35M
Volume · Oct 2 804.19K Avg daily vol (3M) 659.47K

HeartBeam, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for HeartBeam, Inc. (BEAT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q2
2026-08-13
HeartBeam, Inc. (BEAT) Q2 2026 Earnings Call Transcript
Confident tone Form factors (card, patch, remote unit) and use cases Heart attack detection (MI) pivotal study and FDA submission Integrated network partnerships (ER / hospital workflow)
Diluted EPS
$-0.10
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
HeartBeam, Inc. (BEAT) Q1 2026 Earnings Call Transcript
Confident tone Heart Attack Detection (Align ACS) Revenue Timing and Guidance Clinical Feedback and Differentiation
Diluted EPS
$-0.12
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
HeartBeam, Inc. (BEAT) Q4 2025 Earnings Call Transcript
Confident tone Limited Commercial Launch in Concierge/Preventive Cardiology 12-Lead ECG Patch Platform Heart Attack Detection Development
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
HeartBeam, Inc. (BEAT) Q3 2025 Earnings Call Transcript
Confident tone HeartNexus cardiology reader service agreement Commercial launch and go-to-market strategy FDA 510(k) clearance for 12-Lead synthesis software
Diluted EPS
$-0.15
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
HeartBeam, Inc. (BEAT) Q2 2025 Earnings Call Transcript
Confident tone Product ecosystem Commercial readiness and pilot launch Competitive positioning
Diluted EPS
$-0.15
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
HeartBeam, Inc. (BEAT) Q1 2025 Earnings Call Transcript
Confident tone AccurKardia collaboration FDA 510(k) regulatory progress VALID-ECG pivotal study
Diluted EPS
$-0.18
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript
Confident tone Financing and capital FDA clearance milestones Commercialization strategy
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript
Positive tone Technology and platform Upcoming milestones FDA submission and clearance
Diluted EPS
$-0.19
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript
Confident tone AIMIGo product platform FDA clearance progress for AIMIGo Market opportunity and expansion roadmap
Diluted EPS
$-0.19
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
HeartBeam, Inc. (BEAT) Q1 2024 Earnings Call Transcript
Confident tone FDA 510(k) clearance for AIMIGo Valid ECG pivotal study AI / deep learning algorithm development
Diluted EPS
$-0.17
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
HeartBeam, Inc. (BEAT) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.13
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
HeartBeam, Inc. (BEAT) Q2 2023 Earnings Call Transcript
Diluted EPS
$-0.16
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
HeartBeam, Inc. (BEAT) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.50
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
HeartBeam, Inc. (BEAT) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
HeartBeam, Inc. (BEAT) Q3 2022 Earnings Call Transcript
Diluted EPS
$-0.44
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
HeartBeam, Inc. (BEAT) Q2 2022 Earnings Call Transcript
Diluted EPS
$-0.43
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
HeartBeam, Inc. (BEAT) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
HeartBeam, Inc. (BEAT) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–19 of 19 webcasts
Key facts CIK 1779372 13F (30d) 1 filings 1 filers Visit website Investor relations